openPR Logo
Press release

Oncology Informatics Market Size Triumph: Propelling Forward with 7.9% CAGR by 2031

06-23-2024 08:28 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Oncology Informatics Market Size Triumph: Propelling Forward

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oncology Informatics Market- by Types (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support Systems (CDSS), Drug Discovery and Development Informatics, and Image Analytics), End-Users (Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, and Others (Hospitals and Other Care Facilities)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1032

According to the latest research by InsightAce Analytic, the global Oncology Informatics market is valued at US$ 6.06 Billion in 2022, and it is expected to reach US$ 11.81 Billion by 2031, with a CAGR of 7.9 % during a forecast period of 2024-2031.

The field of medicine that deals with cancer prevention, diagnosis, and therapy is known as oncology. The three main subspecialties of oncology are medical, surgical, and radiation. Through the developing discipline of oncology informatics, information technology plays a significant role in the fight against cancer. Information science, computer science, and healthcare all converge in oncology informatics. With instruments like computers, clinical guidelines, and information and communication systems, it focuses on gathering, collecting, and using cancer information as comprehensively and effectively as possible.

The primary factors driving the global oncology informatics market are the rising expense of cancer treatment, an increase in the number of cancer patients, and the expanding uptake of oncology-specific EHRs. The lack of adequate data integration results in inefficiency, which wastes resources and introduces errors into clinical workflow, resulting in excessive treatment, harming patients and incurring additional costs. Thus, focusing on lowering readmission rates and medical errors also boosts industry growth. Oncology Informatics Market growth may be constrained throughout the projection period by factors such as a scarcity of medical oncologists, the high cost of installing these solutions, a lack of system compatibility, and data security concerns. Oncology informatics use hasn't exploded recently, but the attractive development prospects in developing countries have encouraged the uptake of the technology.

North America is anticipated to be the major contributor to the Oncology Informatics market over the forecast years due to changing lifestyles, the rising incidence of cancer, and technical developments like CRISPR in cancer treatments. Market expansion will be aided by government support for advancing cancer therapeutics and a jump in the trend of lower medical costs and readmission rates. In addition, the Asia Pacific Oncology Informatics market is expected to grow significantly during the forecast period. The Asia Pacific region's research sector is expanding the quickest in China. The industry is anticipated to grow during the projection period due to increased research projects to develop precision medicine. The main driver propelling the oncology informatics market is rising government investment and pharmaceutical R&D in developing nations.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1032

Major market players operating in the Oncology Informatics market include Cerner Corporation, Change Healthcare, Elekta AB, F. Hoffmann-La Roche Ltd, Hologic, Inc., IBM Corporation, Inspirata, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc., Oncology Analytics, Inc, PerkinElmer, Inc., RELX Group, Sirenas, LLC, UnitedHealth Group, Inc, Varian, Medical Systems, Inc, and other Prominent Players.

Recent collaborations and agreements in the market:
• In October 2020, cancer informatics and digital service providers A relationship between Inspirata and Smart Reporting, a developer of structured medical reporting software, was recently announced. The collaboration improves the Dynamyx Digital Pathology software package with template reporting options to increase pathology reporting productivity.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1032

Market Segments
Global Oncology Informatics Market, by Types, 2024-2031 (Value US$ Mn)
• Electronic Health Records (EHRs)
• Population Health Management (PHM)
• Clinical Decision Support System (CDSS)
• Drug Discovery and Development Informatics
• Image Analytics

Global Oncology Informatics Market, by End-Users, 2024-2031 (Value US$ Mn)
• Pharmaceutical Industry
• Life Science Industry
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers
• Others (Hospitals and Other Care Facilities)

Global Oncology Informatics Market, by Region, 2024-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Oncology Informatics Market, by Country, 2024-2031 (Value US$ Mn)
• U.S.
• Canada

Europe Oncology Informatics Market, by Country, 2024-2031 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Oncology Informatics Market, by Country, 2024-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Oncology Informatics Market, by Country, 2024-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Oncology Informatics Market, by Country, 2024-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Oncology Informatics market
 To receive an industry overview and future trends of the Oncology Informatics market
 To analyze the Oncology Informatics market drivers and challenges
 To get information on the Oncology Informatics market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Oncology Informatics market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1032

info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Informatics Market Size Triumph: Propelling Forward with 7.9% CAGR by 2031 here

News-ID: 3549463 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

Plasma Fractionation Market Robust Expansion is expected to 2031
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),
Plant Phenotyping Market Profit Growth Factors Detailed Analysis Report 2031
Plant Phenotyping Market Profit Growth Factors Detailed Analysis Report 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global xx Market Size, Share & Trends Analysis Report By Product Type (Equipment, Software (Data Acquisition, Image Analysis, System Control, and Others}, and Sensors (Image Sensors, NDVI Sensors, Temperature Sensors, and Others)), by Platform/Carrier type (Conveyor-Based/Modular Systems, Bench-Based Systems, Handheld/Portable Systems, and Drones), by Automation Type (Fully Automated, Semi-Automated, and Manual), by Analysis System Type (Image
Plant Growth Chamber Market Profit Growth Factors Detailed Analysis Report 2031
Plant Growth Chamber Market Profit Growth Factors Detailed Analysis Report 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Plant Growth Chamber Market Size, Share & Trends Analysis Report By Type (Reach-In, Walk-In), By Application (Clinical research, Academic research) , Region, Market Outlook And Industry Analysis 2031" The Plant growth chamber market is estimated to reach over USD 632.61 million by 2031, exhibiting a CAGR of 4.85% during the forecast period. Get Free Access to Demo
Plant Based API Market Demand and Growth Opportunities Detailed Analysis Report 2024-2031
Plant Based API Market Demand and Growth Opportunities Detailed Analysis Report …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plant Based API Market Size, Share & Trends Analysis Report By Type (Alkaloids, Anthocyanins, Flavonoids, Phenolic Acids, Terpenoids, Lignans and Stilbenes, Others), By Application (Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Others)- Market Outlook And Industry Analysis 2031" The plant-based API market is estimated to exhibit a CAGR of 7.49% during the forecast period. Get Free Access to Demo Report,

All 5 Releases


More Releases for Oncology

Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated